Prevalence and cost savings of therapeutic interchange among U.S. hospitals

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jill M SchachtnerRonald Speizer

Abstract

The prevalence and cost savings of therapeutic interchange (TI) among teaching, nonteaching, and investor-owned hospitals in the United States was studied. A survey was sent to all directors of pharmacy at hospitals listed in the 1999 American Hospital Association directory as having more than 100 beds; 463 (29.8%) hospitals responded. The survey elicited data about hospital demographics, the policies and personnel involved in TI, and the estimated cost savings incurred by the use of TI. Eighty-eight percent of teaching, 89% of nonteaching, and 100% of investor-owned hospitals reported having established TI policies and procedures; 88% of responding hospitals reported the use of TI as a means of formulary management. Individuals involved in the decision-making process for TI policies included physicians, pharmacists, and pharmacy and therapeutics committee members. Most responding hospitals reported having an automatic interchange procedure, and few required physician consent before the substitution was made. The most commonly substituted medication classes were histamine H2-receptor antagonists, proton-pump inhibitors, antacids, and quinolones. Differences in TI procedures and the medication classes commonly substituted were n...Continue Reading

Citations

Dec 22, 2004·Journal of General Internal Medicine·Gerald W SmetanaRussell S Phillips
Nov 27, 2007·European Journal of Clinical Pharmacology·Stefanie U WalkWalter E Haefeli
Nov 28, 2018·Journal of Managed Care & Specialty Pharmacy·Thomas VanderholmAlex J Adams
Dec 15, 2016·Applied Clinical Informatics·Shane P StennerChristoph U Lehmann
Oct 20, 2005·Pharmacotherapy·Thomas GrayUNKNOWN American College of Clinical Pharmacy
Jun 10, 2004·The Annals of Pharmacotherapy·Michael G Kendrach, Maisha Kelly-Freeman
Jul 3, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·UNKNOWN ASHP Expert Panel on Medication Cost Management
Oct 16, 2007·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Sunil KripalaniEric A Coleman
Nov 3, 2016·Pharmacotherapy·Karen J McConnellKatherine M Shea
Oct 10, 2020·European Journal of Hospital Pharmacy. Science and Practice·Jaime Barceló-VidalOlivia Ferrández
Nov 28, 2020·Hospital Pharmacy·Ryan A PoppRebecca L Attridge
Jan 22, 2021·European Journal of Hospital Pharmacy. Science and Practice·Marko KrsticFarshid Sadeghipour

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Glen T SchumockRichard K Lewis
American Journal of Hospital Pharmacy
P L DoeringW L Russell
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Pamela E Norstrom, Carolyn M Brown
The Annals of Pharmacotherapy
Glen T SchumockRichard K Lewis
© 2022 Meta ULC. All rights reserved